Fatigue News and Research

RSS

Can SARS-CoV-2 still be transmissible once symptoms have subsided?

Researchers based at the University of Missouri, in partnership with U.S. government science facilities in Maryland, have reported that individuals severely infected with SARS-CoV-2 may be able to continue shedding infectious viral RNA for over three weeks after the symptomatic infection has passed.

22 Mar 2021

INTEGRA’s electronic pipettes eliminate user fatigue and improve pipetting productivity

CDI Labs – a biotechnology company based in Puerto Rico – is using INTEGRA’s VIAFLO and VOYAGER electronic pipettes to streamline workflows and improve accuracy for the development of next generation proteomics products.

From INTEGRA Biosciences 17 Mar 2021

Ferret study shows SARS-CoV-2 airborne transmission dynamics

A team of researchers led by Sander Herfst from Erasmus University Medical Center in The Netherlands suggests severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could spread through the air at a one-meter distance and cause infection in a new ferret model study.

16 Mar 2021

Study proves that postural orthostatic tachycardia syndrome may be an autoimmune disorder

The symptoms of postural orthostatic tachycardia syndrome, or POTS, can be as varied as they are confounding. There can be fatigue, pain, bleeding disorders and anxiety. Heart palpitations and lightheadedness are common.

16 Mar 2021

An increase in the risk of clinical sequelae after SARS-CoV-2 infection

A new piece of research, published on the medRxiv preprint server, focused on the role of factors such as gender, age, hospitalization, etc., in understanding the risks of clinical sequelae in the post-acute phase of COVID-19, in adults aged between 18 and 65 years.

15 Mar 2021

Study of post-acute sequelae of SARS-CoV-2 infection shows persistent symptoms 8 months

Researchers from the US recently studied the prevalence of PASC in a well-characterized cohort of patients to gain insights into the period following acute SARS-CoV-2 infection. The research is posted online to the preprint server medRxiv.

15 Mar 2021

Researchers find no evidence to suggest a link between beta blockers and depression

Drugs such as beta-adrenergic antagonists (beta blockers) have been linked to a range of adverse effects, including depression.

15 Mar 2021

COVID-19 survivors experience symptoms up to 10 months after infection, study finds

Coronavirus disease (COVID-19) symptoms are increasingly recognized to persist among a subset of individuals following acute infection, but features associated with this persistence are not well-understood.

15 Mar 2021

AI-based assessment of of surgical skills

More than one million operations are performed in Switzerland every year. A surgeon's skill has a direct impact on the outcome of the operation.

13 Mar 2021

Vital exhaustion may increase risk of heart attack in never married, divorced and widowed men

Men experiencing vital exhaustion are more likely to have a heart attack, according to research presented today at ESC Acute CardioVascular Care 2021, an online scientific congress of the European Society of Cardiology.

13 Mar 2021

SARS-CoV-2 is extremely sensitive to type I IFN pre-treatment, study finds

Researchers have found that SARS-CoV-2 is extremely sensitive to type I IFN pre-treatment. Therefore, strategies such as focusing on limiting the production of IFN, rather than its function, could restrict the mechanism of SARS-CoV-2 that increases its viral load with delayed or absent symptoms.

12 Mar 2021

Researchers highlight the need to improve diagnosis, treatment of iron deficiency in women

A new article has highlighted the need to improve diagnosis and treatment of one of the most common conditions affecting women worldwide – iron deficiency.

11 Mar 2021

Researchers shed light on T-cell receptor activation in response to infection

Immune cells specialize to ensure the most efficient defense against viruses and other pathogens. Researchers at the University of Basel have shed light on this specialization of T cells and shown that it occurs differently in the context of an acute and a chronic infection.

10 Mar 2021

For Covid ‘long haulers,’ battling for disability benefits adds aggravation to exhaustion

Rickie Andersen took a brief break from work in March after she fell ill. Her cough, fever and chills were typical covid-19 symptoms, but coronavirus tests were so scarce she could not obtain one to confirm the diagnosis.

10 Mar 2021

Five herbal medicines show potent activity against Babesia duncani in the lab

Bay Area Lyme Foundation, a leading sponsor of Lyme disease research in the U.S., today announced the publication of new data finding that five herbal medicines had potent activity compared to commonly-used antibiotics in test tubes against Babesia duncani, a malaria-like parasite found on the West Coast of the U.S. that causes the disease babesiosis.

9 Mar 2021

Buck scientists develop a predictive model to help identify people at risk for severe COVID-19

Researchers at the Buck Institute analyzed data from the COVID-19 Symptom Tracker app used by 3 million people in the United Kingdom, adding the use of immunosuppressant medication, use of a mobility aid, shortness of breath, fever, and fatigue to the list of symptoms and comorbidities that increase the risk for severe COVID-19.

9 Mar 2021

Functional connectivity in brain's fatigue network changes in response to cognitive fatigue

Kessler Foundation researchers have demonstrated changes in the functional connectivity within the 'fatigue network' in response to cognitive fatigue.

8 Mar 2021

Multisystem intervention could potentially prevent or reverse frailty, research shows

Physicians understand frailty as a dysregulation among multiple systems in the body that make it less resilient and unable to recover completely when faced with a physical challenge such as injury or illness.

8 Mar 2021

In-licensed candidate may be an effective intervention for premature infants with respiratory distress syndrome

The Lundquist Institute (TLI) and The Bill & Melinda Gates Medical Research Institute (Gates MRI) executed a license agreement for TLI intellectual property covering a synthetic lung surfactant formulation to be developed for respiratory distress syndrome (RDS) for premature infants in Low- and Middle-Income countries (LMIC).

8 Mar 2021

In-licensed candidate may be an effective intervention for preterm infants with respiratory distress syndrome

8 Mar 2021

Fatigue News and Research

Can SARS-CoV-2 still be transmissible once symptoms have subsided?

INTEGRA’s electronic pipettes eliminate user fatigue and improve pipetting productivity

Ferret study shows SARS-CoV-2 airborne transmission dynamics

Study proves that postural orthostatic tachycardia syndrome may be an autoimmune disorder

An increase in the risk of clinical sequelae after SARS-CoV-2 infection

Study of post-acute sequelae of SARS-CoV-2 infection shows persistent symptoms 8 months

Researchers find no evidence to suggest a link between beta blockers and depression

COVID-19 survivors experience symptoms up to 10 months after infection, study finds

AI-based assessment of of surgical skills

Vital exhaustion may increase risk of heart attack in never married, divorced and widowed men

SARS-CoV-2 is extremely sensitive to type I IFN pre-treatment, study finds

Researchers highlight the need to improve diagnosis, treatment of iron deficiency in women

Researchers shed light on T-cell receptor activation in response to infection

For Covid ‘long haulers,’ battling for disability benefits adds aggravation to exhaustion

Five herbal medicines show potent activity against Babesia duncani in the lab

Buck scientists develop a predictive model to help identify people at risk for severe COVID-19

Functional connectivity in brain's fatigue network changes in response to cognitive fatigue

Multisystem intervention could potentially prevent or reverse frailty, research shows

In-licensed candidate may be an effective intervention for premature infants with respiratory distress syndrome

In-licensed candidate may be an effective intervention for preterm infants with respiratory distress syndrome

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News